Evaluation of Prognostic Factors for Unresectable or Recurrent Gastric Cancer Treated with Nivolumab

被引：0
|
作者：
Kenji Ishido
Satoshi Tanabe
Chikatoshi Katada
Yu Ishibashi
Gen Kitahara
Mie Onoue
Yo Kubota
Yasuaki Furue
Takuya Wada
Akinori Watanabe
Chika Kusano
机构：
[1] Kitasato University School of Medicine,Department of Gastroenterology
[2] Kitasato University School of Medicine,Research and Development Center for New Medical Frontiers
来源：
Journal of Gastrointestinal Cancer | 2023年 / 54卷
关键词：
Gastric cancer; Nivolumab; Neutrophil-to-lymphocyte ratio; Immune-related adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：485 / 491
页数：6
相关论文
共 50 条
  • [41] Evaluation of Important Prognostic Clinical and Pathological Factors in Gastric Cancer
    Cammerer, Gregor
    Formentini, Andrea
    Karletshofer, Markus
    Henne-Bruns, Doris
    Kornmann, Marko
    ANTICANCER RESEARCH, 2012, 32 (05) : 1839 - 1842
  • [42] Extended total gastrectomy after nivolumab for unresectable multivisceral invasive gastric cancer
    Satoshi Toyota
    Hiroshi Naito
    Saki Motoyoshi
    Ryota Nakanishi
    Eiji Oki
    Hiroyuki Orita
    Daisuke Korenaga
    Surgical Case Reports, 6
  • [43] Extended total gastrectomy after nivolumab for unresectable multivisceral invasive gastric cancer
    Toyota, Satoshi
    Naito, Hiroshi
    Motoyoshi, Saki
    Nakanishi, Ryota
    Oki, Eiji
    Orita, Hiroyuki
    Korenaga, Daisuke
    SURGICAL CASE REPORTS, 2020, 6 (01)
  • [44] Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: A retrospective study
    Ogata, T.
    Satake, H.
    Ogata, M.
    Hatachi, Y.
    Yasui, H.
    ANNALS OF ONCOLOGY, 2018, 29 : 19 - 19
  • [45] Pretreatment Glasgow prognostic score as a predictor of outcomes in nivolumab-treated patients with advanced gastric cancer
    Tokuyama, Nagahiro
    Takegawa, Naoki
    Nishikawa, Michiko
    Sakai, Aya
    Mimura, Takuya
    Kushida, Saeko
    Tsumura, Hidetaka
    Yamamoto, Yoshinobu
    Miki, Ikuya
    Tsuda, Masahiro
    PLOS ONE, 2021, 16 (02):
  • [46] Neutrophil-to-lymphocyte ratio and C-reactive protein-to-albumin ratio as prognostic factors for unresectable advanced or recurrent gastric cancer
    Namikawa, Tsutomu
    Shimizu, Shigeto
    Yokota, Keiichiro
    Tanioka, Nobuhisa
    Munekage, Masaya
    Uemura, Sunao
    Maeda, Hiromichi
    Kitagawa, Hiroyuki
    Kobayashi, Michiya
    Hanazaki, Kazuhiro
    LANGENBECKS ARCHIVES OF SURGERY, 2022, 407 (02) : 609 - 621
  • [47] Prognostic factors in gastric cancer
    Allgayer, H
    Heiss, MM
    Schildberg, FW
    BRITISH JOURNAL OF SURGERY, 1997, 84 (12) : 1651 - 1664
  • [48] Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer
    Mimura, Kosaku
    Ogata, Takashi
    Yoshimoto, Yuya
    Yoshida, Daisaku
    Nakajima, Shotaro
    Sato, Hisashi
    Machida, Nozomu
    Yamada, Takanobu
    Watanabe, Yohei
    Tamaki, Tomoaki
    Fujikawa, Hirohito
    Inokuchi, Yasuhiro
    Hayase, Suguru
    Hanayama, Hiroyuki
    Saze, Zenichiro
    Katoh, Hiroyuki
    Takahashi, Fumiaki
    Oshima, Takashi
    Suzuki, Yoshiyuki
    Kono, Koji
    COMMUNICATIONS MEDICINE, 2023, 3 (01):
  • [49] Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer
    Kosaku Mimura
    Takashi Ogata
    Yuya Yoshimoto
    Daisaku Yoshida
    Shotaro Nakajima
    Hisashi Sato
    Nozomu Machida
    Takanobu Yamada
    Yohei Watanabe
    Tomoaki Tamaki
    Hirohito Fujikawa
    Yasuhiro Inokuchi
    Suguru Hayase
    Hiroyuki Hanayama
    Zenichiro Saze
    Hiroyuki Katoh
    Fumiaki Takahashi
    Takashi Oshima
    Yoshiyuki Suzuki
    Koji Kono
    Communications Medicine, 3
  • [50] Prognostic factors in gastric cancer
    Brien, TP
    Depowski, PL
    Sheehan, CE
    Ross, JS
    McKenna, BJ
    MODERN PATHOLOGY, 1998, 11 (09) : 870 - 877
12345